Phase I Study of a Statin + Erlotinib for Advanced Solid Malignancies With Focus on Squamous Cell Carcinomas and NSCLC
Clinical trial NCT00966472 · COMPLETED
Trial details
- NCT number
- NCT00966472
- Sponsor
- Ottawa Hospital Research Institute
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-03-01
- Primary completion
- 2014-09-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.